App-Quantinova.ai

Analysis of total tumor load of sentinel lymph node as a prognostic factor in patients with early breast cancer.

Vicente Peg - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Breast cancer histology and non-sentinel lymph node involvement following a positive sentinel lymph node biopsy: A multi-institutional cohort study.

Alana Hosein - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

TARGIT E(lderly): Prospective phase II study of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer.

Frederik K. Wenz - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Can radiation therapy adequately address positive surgical margins in elderly women (70 years) with stage I ER+ breast cancer?

Kaelen Medeiros - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1 to 3 positive lymph nodes in the modern treatment era.

Minoru Miyashita - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

A model to predict axillary nodal pathologic complete response following neoadjuvant chemotherapy for breast cancer.

Olga Kantor - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Management of lobular carcinoma in situ: A decision analysis.

Stephanie M Wong - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Effect of elevated BMI on radiation toxicity in early stage breast cancer patients.

Jordan Silberg - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Beyond the margins: Economic costs and complication rates associated with repeated breast-conserving surgeries.

Leanne N. Metcalfe - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Relationship between rising bilateral mastectomy rates and increased use of neoadjuvant chemotherapy (NAC) in California, 1998-2012.

Irene Wapnir - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Impact of breast magnetic resonance imaging (MRI) on long-term outcome after breast conservation therapy (BCT).

Carolyn J. Kushner - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

A combination of histology and CK19 mRNA transcripts in sentinel lymph nodes for axillary lymph node staging and prognostication in patients with breast cancer.

Takayuki Kinoshita - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Locoregional treatment (LRT) and overall survival (OS) of men with T1a,b,cN0M0 breast cancer: a population-based study.

Jose Pablo Leone - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Survival outcomes after adjuvant radiation in women 65 years diagnosed with ductal carcinoma in-situ: Analysis of National Cancer Data Base.

Wenli Gao - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Optimal patient selection for electron intraoperative radiotherapy (IORT) as sole treatment for breast cancer.

Kathleen C. Horst - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

MRI for depicting DCIS components of invasive breast cancers prior to surgery.

Christiane K. Kuhl - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Hypofractionated whole breast IMRT and brachytherapy boost after conservative surgery for breast cancer: Early results of a prospective non-randomised trial.

Benjamin Guix - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Trends in mastectomy rates over time in elderly women with stage I, hormone-sensitive breast cancer: A SEER-based study.

Jose G. Bazan - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Clinical implication of internal mammary lymph node biopsy during immediate breast reconstruction using autologous tissue free flaps in breast cancer surgery.

Han-Byoel Lee - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Rate of sentinel lymph node biopsy in patients undergoing mastectomy for ductal carcinoma in situ with and without micro-invasion.

Patience Odele - American Society of Clinical Oncology (ASCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Filters

14023 Abstracts